XML 29 R23.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Accounting Policies [Abstract] |
The following table provides information about disaggregated revenue by product mix for the years ended December 31, 2019, 2018, and 2017: | The following table provides information about disaggregated revenue by product mix for the years ended December 31, 2019, 2018, and 2017:
|  | For the Years Ended December 31, |
|  | 2019 |  |  | 2018 |  |  | 2017 |
Prescription vitamins |  | $ | 9,885,493 |  |  | $ | 15,041,259 |  |  | $ | 16,744,831 |
IMVEXXY |  |  | 16,252,045 |  |  |  | 1,058,201 |  |  |  | — |
BIJUVA |  |  | 1,836,443 |  |  |  | — |  |  |  | — |
ANNOVERA |  |  | 6,166,556 |  |  |  | — |  |  |  | — |
License revenue |  |  | 15,506,400 |  |  |  | — |  |  |  | — |
OTC products |  |  | — |  |  |  | — |  |  |  | 32,882 |
Net revenue |  | $ | 49,646,937 |  |  | $ | 16,099,460 |  |  | $ | 16,777,713 |
The table below presents potentially dilutive securities that could affect our calculation of diluted net loss per share allocable to common stockholders for the periods presented. | The table below presents potentially dilutive securities that could affect our calculation of diluted net loss per share allocable to common stockholders for the periods presented.
|  | As of December 31, |
|  | 2019 |  |  | 2018 |  |  | 2017 |
Stock options |  |  | 25,030,234 |  |  |  | 20,872,824 |  |  |  | 23,365,225 |
Warrants |  |  | 1,832,571 |  |  |  | 3,007,571 |  |  |  | 3,115,905 |
Restricted stock awards |  |  | 1,240,000 |  |  |  | 1,040,000 |  |  |  | — |
|  |  | 28,102,805 |  |  |  | 24,920,395 |  |  |  | 26,481,130 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration